ImpediMed Company Description
ImpediMed Limited, a medical technology company, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices in the Unites States and Europe.
The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema and deliver snapshot of fluid status and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-car body composition analysis; and HF-Dex analysis for point-or care heart failure fluid assessment.
It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications.
The company was incorporated in 1999 and is headquartered in Carlsbad, California.

Country | Australia |
Founded | 1999 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 83 |
CEO | Parmjot Bains |
Contact Details
Address: 5900 Pasteur Ct. Carlsbad, 92008 United States | |
Phone | 760 585 2100 |
Website | impedimed.com |
Stock Details
Ticker Symbol | IPD |
Exchange | Australian Securities Exchange |
Fiscal Year | July - June |
Reporting Currency | AUD |
ISIN Number | AU000000IPD8 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Dr. Parmjot Bains M.D. | MD, Chief Executive Officer and Director |
McGregor Grant BEc, C.A., FCIS, GAICD | Chief Financial Officer and Executive Director |
Dennis Schlaht | Senior Vice President of Research & Development and Technology |
Ashley Munoz | Director of Human Resources |
Dr. Steven Chen M.B.A., M.D. | Chief Medical Center |
Leanne Ralph AAICD, ACIS, BBus | Company Secretary |
Dr. Walton A. Taylor | Medical Director |